How much should we invest in antibiotics? Investigating their option value

Research output: Contribution to conferenceAbstract

Abstract

The existing business models for antibiotics fail to promote antibiotics stewardship to preserve our existing portfolio of drugs, while at the same time funding for research and development has been insufficient in recent decades, as only two novel classes of antibiotics have been introduced since the 1970s. The UK is considering novel mechanisms for paying for antibiotics to overcome these issues. We will explore the option value for preserving novel antibiotics for extreme events. We will discuss the option value implications for investment in new antibiotics and possible extensions to the model.
Original languageEnglish
Publication statusPublished - 29 Jul 2019
EventINFORMS Healthcare 2019 - Massachusetts Institute of Technology (MIT), Cambridge, United States
Duration: 26 Jul 201930 Jul 2019
http://meetings2.informs.org/wordpress/healthcare2019/

Conference

ConferenceINFORMS Healthcare 2019
CountryUnited States
CityCambridge
Period26/07/1930/07/19
Internet address

Keywords

  • healthcare management
  • antibiotics
  • drug investment

Fingerprint Dive into the research topics of 'How much should we invest in antibiotics? Investigating their option value'. Together they form a unique fingerprint.

  • Research Output

    Open Access
    File
  • 6 Citations (Scopus)
    2 Downloads (Pure)

    Activities

    • 2 Invited talk

    The option vlaue of antibiotics (in the context of market pull-mechanisms)

    Itamar Megiddo (Speaker)
    9 May 2019

    Activity: Talk or presentation typesInvited talk

    The option value of antibiotics

    Itamar Megiddo (Speaker)
    16 May 2019

    Activity: Talk or presentation typesInvited talk

    Cite this

    Megiddo, I. (2019). How much should we invest in antibiotics? Investigating their option value. Abstract from INFORMS Healthcare 2019, Cambridge, United States.